SCHEMBL368967

SCHEMBL368967

CCOC(=O)c1cc(Oc2ccc(C(CC(=O)c3ccc(=O)n(C)c3)c3ccc(Cl)cc3C)cc2)ccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.40
BAZ2A Q9UIF9 1/20 0.40
FFAR1 O14842 5/20 0.38
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KMT2A Q03164 1/20 0.34
CYP1A2 P05177 3/20 0.34
POLB P06746 2/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
TEAD2 Q15562 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL368539 0.92 FFAR1 (0.37) FFAR1CYP2C9ALDH1A1KMT2APOLB
SCHEMBL369921 0.90 BAZ2B (0.36) BAZ2BBAZ2AFFAR1L3MBTL1
SCHEMBL369771 0.86 P2RX3 (0.37) FFAR1POLBFNTAFNTB
SCHEMBL369275 0.86 P2RX3 (0.39) FFAR1CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL368992 0.84 CREBBP (0.41) CYP2C9KMT2APOLB
SCHEMBL368801 0.83 P2RX3 (0.42) FFAR1LMNAFNTAFNTBL3MBTL1
SCHEMBL1389758 0.82 GPBAR1 (0.36) FFAR1ALDH1A1FNTAFNTB
SCHEMBL1389755 0.82 GPBAR1 (0.36) FFAR1ALDH1A1FNTAFNTB
SCHEMBL371041 0.82 FFAR1 (0.37) FFAR1POLB
SCHEMBL1390419 0.81 LMNA (0.43) FFAR1CYP2C9CYP2C19KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 BAZ2B 3289/4885BAZ2A 3547/4885FFAR1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.